5-tert-butyl-N-pyrazol-4-yl-4,5,6,7-tetrahydroben... [J Med Chem. 2008] - PubMed

Save items

loading

Related citations in PubMed

A discovery of novel Mycobacterium tuberculosis pantothenate synthetase inhibitors based on the molecular mechanism of actinomycin D inhibition. [Bioorg Med Chem Lett. 2011]
A discovery of novel Mycobacterium tuberculosis pantothenate synthetase inhibitors based on the molecular mechanism of actinomycin D inhibition.
Yang Y, Gao P, Liu Y, Ji X, Gan M, Guan Y, Hao X, Li Z, Xiao C. Bioorg Med Chem Lett. 2011 Jul 1; 21(13):3943-6. Epub 2011 May 14.
Discovery and development of the covalent hydrates of trifluoromethylated pyrazoles as riboflavin synthase inhibitors with antibiotic activity against Mycobacterium tuberculosis. [J Org Chem. 2009]
Discovery and development of the covalent hydrates of trifluoromethylated pyrazoles as riboflavin synthase inhibitors with antibiotic activity against Mycobacterium tuberculosis.
Zhao Y, Bacher A, Illarionov B, Fischer M, Georg G, Ye QZ, Fanwick PE, Franzblau SG, Wan B, Cushman M. J Org Chem. 2009 Aug 7; 74(15):5297-303.
Searching for new cures for tuberculosis: design, synthesis, and biological evaluation of 2-methylbenzothiazoles. [J Med Chem. 2009]
Searching for new cures for tuberculosis: design, synthesis, and biological evaluation of 2-methylbenzothiazoles.
Huang Q, Mao J, Wan B, Wang Y, Brun R, Franzblau SG, Kozikowski AP. J Med Chem. 2009 Nov 12; 52(21):6757-67.
Review Recent developments in antitubercular drugs. [Mini Rev Med Chem. 2008]
Review Recent developments in antitubercular drugs.
Ahirrao P. Mini Rev Med Chem. 2008 Dec; 8(14):1441-51.
Review Structural biology and biochemistry of cytochrome P450 systems in Mycobacterium tuberculosis. [Drug Metab Rev. 2008]
Review Structural biology and biochemistry of cytochrome P450 systems in Mycobacterium tuberculosis.
McLean KJ, Munro AW. Drug Metab Rev. 2008; 40(3):427-46.

See reviews... See all...

Cited by 7 PubMed Central articles

Priming with a Recombinant Pantothenate Auxotroph of Mycobacterium bovis BCG and Boosting with MVA Elicits HIV-1 Gag Specific CD8(+) T Cells. [PLoS One. 2012]
Priming with a Recombinant Pantothenate Auxotroph of Mycobacterium bovis BCG and Boosting with MVA Elicits HIV-1 Gag Specific CD8(+) T Cells.
Chapman R, Shephard E, Stutz H, Douglass N, Sambandamurthy V, Garcia I, Ryffel B, Jacobs W, Williamson AL. PLoS One. 2012; 7(3):e32769. Epub 2012 Mar 29.
(E)-3-(4-Chloro-phen-yl)-3-[3-(4-chloro-phen-yl)-1H-pyrazol-1-yl]prop-2-enal. [Acta Crystallogr Sect E Struct...]
(E)-3-(4-Chloro-phen-yl)-3-[3-(4-chloro-phen-yl)-1H-pyrazol-1-yl]prop-2-enal.
Susindran V, Athimoolam S, Bahadur SA, Manikannan R, Muthusubramanian S. Acta Crystallogr Sect E Struct Rep Online. 2010 Sep 18; 66(Pt 10):o2594-5. Epub 2010 Sep 18.
5-(1-Cyclo-hexen-1-yl)-3-(4-methoxy-phen-yl)isoxazole. [Acta Crystallogr Sect E Struct...]
5-(1-Cyclo-hexen-1-yl)-3-(4-methoxy-phen-yl)isoxazole.
Vallejos G, Gutierrez M, Astudillo L, Brito I, Cárdenas A. Acta Crystallogr Sect E Struct Rep Online. 2009 Mar 28; 65(Pt 4):o920. Epub 2009 Mar 28.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
BioAssay
PubChem BioAssay experiments on the biological activities of small molecules that cite the current articles. The depositors of BioAssay data provide these references.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

5-tert-butyl-N-pyrazol-4-yl-4,5,6,7-tetrahydrobenzo[d]isoxazole-3-carboxamide de...
5-tert-butyl-N-pyrazol-4-yl-4,5,6,7-tetrahydrobenzo[d]isoxazole-3-carboxamide derivatives as novel potent inhibitors of Mycobacterium tuberculosis pantothenate synthetase: initiating a quest for new antitubercular drugs.
J Med Chem. 2008 Apr 10 ;51(7):1999-2002. Epub 2008 Mar 13 .

PubMed
The use of acellular matrices for the tissue engineering of cardiac valves.
The use of acellular matrices for the tissue engineering of cardiac valves.
Proc Inst Mech Eng H. 2008 Jan ;222(1):129-43.

PubMed
Brewer's/baker's yeast (Saccharomyces cerevisiae) and preventive medicine: Part ...
Brewer's/baker's yeast (Saccharomyces cerevisiae) and preventive medicine: Part II.
Urol Nurs. 2008 Feb ;28(1):73-5.

PubMed
Nuclear factor I gene expression in the developing forebrain.
Nuclear factor I gene expression in the developing forebrain.
J Comp Neurol. 2008 May 20 ;508(3):385-401.

PubMed
Advanced glycation end products induce in vitro cross-linking of alpha-synuclein...
Advanced glycation end products induce in vitro cross-linking of alpha-synuclein and accelerate the process of intracellular inclusion body formation.
J Neurosci Res. 2008 Jul ;86(9):2071-82.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

5-tert-butyl-N-pyrazol-4-yl-4,5,6,7-tetrahydrobenzo[d]isoxazole-3-carboxamide derivatives as novel potent inhibitors of Mycobacterium tuberculosis pantothenate synthetase: initiating a quest for new antitubercular drugs.

Source

Abstract

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

Supplemental Content

Save items

Related citations in PubMed

Cited by 7 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information